Cargando…

Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis

INTRODUCTION: Chronic venous disease (CVD) is a common condition associated with valvular dysfunction, venous hypertension and endothelial inflammation. Sulodexide facilitates the healing of venous ulcers and is frequently used in patients with CVD without ulcer. This review assessed the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bignamini, Angelo A., Matuška, Jiří
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089759/ https://www.ncbi.nlm.nih.gov/pubmed/31989486 http://dx.doi.org/10.1007/s12325-020-01232-1

Ejemplares similares

Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021)

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Andreozzi, Giuseppe M., et al.
Publicado: (2015)

Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Jiang, Qing-Jun, et al.
Publicado: (2018)

Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life
por: Elleuch, Nizar, et al.
Publicado: (2016)

Use of sulodexide in patients with peripheral vascular disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2010)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Development and use of sulodexide in vascular diseases: implications for treatment
por: Coccheri, Sergio, et al.
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Sulodexide improves pain-free walking distance in patients with lower extremity peripheral arterial disease: A systematic review and meta-analysis
por: Gaddi, Antonio Vittorino, et al.
Publicado: (2020)

Pharmacological adjuncts for chronic venous ulcer healing
por: Coccheri, Sergio, et al.
Publicado: (2015)

Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review
por: Li, Rui, et al.
Publicado: (2015)

Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1
por: Kaczmarek, Barbara, et al.
Publicado: (2023)

A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency
por: Chong, Nyuk Jet, et al.
Publicado: (2013)

Sulodexide in IgA nephropathy
Publicado: (2013)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
por: Pompilio, Giuseppe, et al.
Publicado: (2020)

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs
por: Serra, Raffaele, et al.
Publicado: (2014)

Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
por: Gaddi, Antonio V, et al.
Publicado: (2010)

Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021)

The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2021)

Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011)

Inhibition of neointimal proliferation of rat carotid artery by sulodexide.
por: Park, H. Y., et al.
Publicado: (1997)

A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide
por: Song, Chang Hwa, et al.
Publicado: (2020)

Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis
por: Htun, Tha Pyai, et al.
Publicado: (2021)

Sulodexide reduces senescence-related changes in human endothelial cells
por: Suminska-Jasinska, Katarzyna, et al.
Publicado: (2011)

Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats
por: Yin, Jianyong, et al.
Publicado: (2016)

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?
por: Szolnoky, Győző, et al.
Publicado: (2022)

Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: The results of TUN-EndCOV study
por: Charfeddine, S., et al.
Publicado: (2022)

Associations between signs and symptoms of dry eye disease: a systematic review
por: Bartlett, Jimmy D, et al.
Publicado: (2015)

Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19
por: Melkumyants, Arthur, et al.
Publicado: (2022)

Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion
por: Yuan, Tao, et al.
Publicado: (2021)

Sulodexide reduces glucose induced senescence in human retinal endothelial cells
por: Gericke, A., et al.
Publicado: (2021)

A systematic review and meta-analysis of pregnancy and COVID-19: Signs and symptoms, laboratory tests, and perinatal outcomes
por: Hassanipour, Soheil, et al.
Publicado: (2020)

Association of clinical signs and symptoms of Ebola viral disease with case fatality: a systematic review and meta-analysis
por: Moole, Harsha, et al.
Publicado: (2015)

Retinal Vascular Signs as Screening and Prognostic Factors for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Current Evidence
por: Aronov, Michael, et al.
Publicado: (2021)

Systematic literature review of the signs and symptoms of respiratory syncytial virus
por: Colosia, Ann, et al.
Publicado: (2023)

Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy
por: Jo, Hyoung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ami3lb4fv6sjmghot7igvpo7pp